Stifel Financial’s IceCure Medical ICCM Stock Holding History

Stifel Financial’s Portfolio ICCM Stock Details ICCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$52.6K	Buy	+32,600	New	+$91.4K	﹤0.01%	3696

Other funds holding ICCM

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Gunderson Capital Management Mt. Pleasant, South Carolina $359M AUM 176.83% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Bartlett & Co Wealth Management Cincinnati, Ohio $8.23B AUM 17.87% 1-Year Est. Return

Stifel Financial's ICCM Position: Q3 2026 in Review

Stifel Financial opened a new position in IceCure Medical (ICCM) in Q3 2026: 32,600 shares worth $52.6K. The stake represents ﹤0.01% of the portfolio and ranks #3696 among its holdings.

9 funds tracked by Wall St. Rank hold ICCM as of Q3 2026.

Stifel Financial held 32,600 shares of IceCure Medical worth $52.6K as of Q3 2026.
IceCure Medical was a new Stifel Financial position in Q3 2026.
IceCure Medical made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #3696 holding.
9 funds tracked by Wall St. Rank held IceCure Medical as of Q3 2026.

Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.